Patents by Inventor Denis Blache

Denis Blache has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for instantaneously determining rates of distortion of signals on an AC electrical network, and associated device
    Patent number: 8717040
    Abstract: A method for instantaneously determining rates of distortion on variable frequency signals, and an associated device, in which a harmonic distortion rate is calculated across the shortest possible temporal window, corresponding to the duration of a period of a given signal's fundamental. Hence, the aim being to precisely determine the signal frequency value, whose HDR is to be calculated, an iteration of certain measurements, achieved at the time of a given calculation, is embodied in order to calculate the HDR on subsequent signals.
    Type: Grant
    Filed: June 12, 2007
    Date of Patent: May 6, 2014
    Assignee: Airbus Operations SAS
    Inventors: Marc Weber, Aymeric Plo, Denis Blache
  • AQUEOUS SALINE SOLUTIONS FOR THE DESTRUCTION OF FATTY TISSUE
    Publication number: 20110262562
    Abstract: The invention relates to aqueous saline solutions with an osmolarity of 50 mOsm/L to 170 mOsm/L, which further include at least one membrane-weakening agent. The invention also relates to a cosmetic composition which includes one of said solutions, as well as to the use of one of said solutions to obtain a drug for treating cellulite, steatomery, and lipomas.
    Type: Application
    Filed: October 27, 2009
    Publication date: October 27, 2011
    Applicant: LIPOLYANE
    Inventors: Yves Crassas, Denis Blache
  • Method for inhibiting blood-platelet aggregration with .beta.-naphthoquinone compounds
    Patent number: 5523322
    Abstract: A method of inhibiting blood-platelet aggregation in warm-blooded animals comprising administering to warm-blooded animals a blood-platelet aggregation inhibiting effective amount of a compound selected from the group consisting of a compound of the formula ##STR1## wherein R is selected from the group consisting of --NH--CO--NH.sub.2, --NH--CO--CH.sub.3, --OH and their non-toxic, pharmaceutically acceptable acid addition salts.
    Type: Grant
    Filed: June 30, 1994
    Date of Patent: June 4, 1996
    Assignee: Roussel UCLAF
    Inventors: Denis Blache, Christian Bloy, Bernard Hercelin